AptarGroup, Inc. (ATR)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 159.22 |
| Open | 160.94 |
| Bid | 0.00 x 1000 |
| Ask | 0.00 x 1000 |
| Day's Range | 160.35 - 161.92 |
| 52 Week Range | 120.36 - 161.92 |
| Volume | |
| Avg. Volume | 276,912 |
| Market Cap | 10.725B |
| Beta (5Y Monthly) | 0.57 |
| PE Ratio (TTM) | 34.01 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 1.80 (1.11%) |
| Ex-Dividend Date | Oct 24, 2024 |
| 1y Target Est | N/A |
- Business Wire
Aptar Announces New $500 Million Share Repurchase Authorization and Declares Quarterly Dividend
CRYSTAL LAKE, Ill., October 10, 2024--Aptar Announces New $500 Million Share Repurchase Authorization and Declares Quarterly Dividend
- Business Wire
Aptar’s N-Sorb Nitrosamine Mitigation Solution Accepted to US FDA’s Emerging Technology Program
CRYSTAL LAKE, Ill., September 23, 2024--Aptar’s N-Sorb Nitrosamine Mitigation Solution Accepted to US FDA’s Emerging Technology Program
- Business Wire
Aptar’s Nasal Unidose System to Deliver neffy® (epinephrine nasal spray), the First and Only FDA-Approved Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis
CRYSTAL LAKE, Ill., August 15, 2024--Aptar’s Nasal Unidose System to Deliver neffy® (epinephrine nasal spray)
© 2024 Yahoo. All rights reserved.